Recent Finacing
Recent Raise
Eliem Therapeutics is a clinical-stage biotech developing therapies to rebalance neuronal excitation and inhibition for chronic pain, epilepsy, depression and anxiety, advancing ETX-810, ETX-155, and Kv7/opener and anxiolytic preclinical programs.
